161 results
8-K
EX-99.1
FGEN
FibroGen Inc
26 Feb 24
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
in China, Europe, Japan, and numerous other countries for the treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis
8-K
EX-99.1
FGEN
FibroGen Inc
6 Nov 23
FibroGen Reports Third Quarter 2023 Financial Results
4:05pm
based on value share in the anemia of chronic kidney disease market in China.
1 Total roxadustat net sales in China includes sales made
8-K
EX-99.1
8rd a6hijdh2
7 Aug 23
FibroGen Reports Second Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
2hijnq6
26 Jun 23
FibroGen Announces Topline Results from Phase 3 ZEPHYRUS-1 Study of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis
9:05am
8-K
EX-99.1
76rsd
8 May 23
FibroGen Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
tzrp96hf2h6rzf ufy2k
7 Nov 22
FibroGen Reports Third Quarter 2022 Financial Results
4:06pm
S-3ASR
vgmqy
8 Aug 22
Automatic shelf registration
5:12pm
S-3ASR
EX-1.2
hnhch04
8 Aug 22
Automatic shelf registration
5:12pm
8-K
EX-99.1
w46sy60 o8
8 Aug 22
FibroGen Reports Second Quarter 2022 Financial Results
4:07pm